Nfj Investment Group »

BioCryst Pharmaceuticals shares owned by Nfj Investment Group

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Nfj Investment Group from 13F filings

Historical chart of Nfj Investment Group investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Nfj Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Nfj Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.8M 279k 10.00

More positions owned by Nfj Investment Group

Hf Sinclair Corp (DINO)
Apple (AAPL)
Ge Vernova (GEV)
Eli Lilly & Co. (LLY)
Charles Schwab Corporation (SCHW)
Alphabet Cap Stk Cl A (GOOGL)
Hershey Company (HSY)
Microsoft Corporation (MSFT)
Prologis (PLD)
Allstate Corporation (ALL)
Amphenol Corp Cl A (APH)
JPMorgan Chase & Co. (JPM)
UMB Financial Corporation (UMBF)
EOG Resources (EOG)
Marathon Petroleum Corp (MPC)

View all positions for Nfj Investment Group

Top funds holding BioCryst Pharmaceuticals

BlackRock
RA Capital Management
Deerfield Management Company
State Street Corporation
Vanguard Capital Management
Vanguard Portfolio Management
TCG Crossover Management
Perceptive Advisors
Jupiter Topco
Henderson Group
Vestal Point Capital
Two Sigma Investments
Geode Capital Management
Standard Life Aberdeen
UBS Group

View all funds holding BioCryst Pharmaceuticals